Tauriga Sciences Inc. Products Offerings Now Available on Amazon Prime

NEW YORK, NY – (NewMediaWire) – September 16, 2021 – Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the
“Company”), a New York based diversified Life Sciences Company, today announced
that its proprietary product offerings are now available on Amazon Prime.  Currently, 3 SKUs of the Company’s flagship
brand Tauri-Gum™, as well as its Tauri-Pet™ dog treats – are available to
Amazon Prime customers.  

Amazon Prime is a paid subscription program from Amazon which is available in various countries and gives users
access to additional services otherwise unavailable or available at a premium
to other Amazon customers. Services include same, one or two-day delivery of
goods and streaming music, video, e-books, gaming and grocery shopping
services. In April 2021, Amazon reported that Prime had more than 200 million
subscribers worldwide.

In other news, the Company continues to experience strong
levels of revenue growth and new customer acquisition. 

Link to Tauriga Sciences Inc. E-Comm Website:

Link to Amazon “Tauri-Gum” Product(s) Page:


Tauriga Sciences, Inc. (TAUG) is a revenue generating,
diversified life sciences company, engaged in several major business activities
and initiatives.  The company manufactures and distributes several
proprietary retail products and product lines, mainly focused on the
Cannabidiol (“CBD”) and Cannabigerol (“CBG”) Edibles market
segment.  The main product line, branded as Tauri-Gum™, consists of a
proprietary supplement chewing gum that is Kosher certified, Halal certified,
and Vegan Formulated (CBD Infused Tauri-Gum™ Flavors: Mint, Blood Orange,
Pomegranate), (CBG Infused Tauri-Gum™ Flavors: Peach-Lemon, Black Currant),
(DELTA 8 THC Infused Tauri-Gum™ Flavor: Evergreen Mint), (Vitamin C + Zinc
Infused Tauri-Gum™ Flavor: Pear Bellini), (Caffeine Infused Tauri-Gum™ Flavor:
Cherry Lime Rickey), & (Vitamin D3 Infused Tauri-Gum™ Flavor: Golden
Raspberry).  The Company’s commercialization strategy consists of a
broad array of retail customers, distributors, and a fast-growing E-Commerce
business segment (E-Commerce website: Please visit our
corporate website, for additional information, as well as inquiries,

Complementary to the Company’s retail business, is its
ongoing Pharmaceutical Development initiative.  This relates to the
development of a proposed Pharmaceutical grade version of Tauri-Gum™, for
nausea regulation (specifically designed for the following indication: Patients
Subjected to Ongoing Chemotherapy Treatment). On March 22, 2021, the Company
announced that it had Converted its U.S. Provisional Patent Application (filed
on March 17, 2020) into a U.S. Non-Provisional Patent
Application.  The Patent, filed with the U.S.P.T.O. is Titled
On December 18, 2020 the Company disclosed that it had entered into a Master
Services Agreement with CSTI to lead the Company’s clinical development

The Company is headquartered in Wappingers Falls, New
York.  In addition, the Company operates two full time E-Commerce
fulfillment centers: one located in Montgomery, Texas and the other in
Brooklyn, New York.

DISCLAIMER — Forward-Looking Statements

This press release contains certain “forward-looking
statements” as defined by the Private Securities Litigation Reform Act of 1995
which represent management’s beliefs and assumptions concerning future events.
These forward-looking statements are often indicated by using words such as
“may,” “will,” “expects,” “anticipates,” believes, “hopes,” “believes,” or
plans, and may include statements regarding corporate objectives as well as the
attainment of certain corporate goals and milestones. Forward-looking statements
are based on present circumstances and on management’s present beliefs with
respect to events that have not occurred, that may not occur, or that may occur
with different consequences or timing than those now assumed or anticipated.
Actual results may differ materially from those expressed in forward looking
statements due to known and unknown risks and uncertainties, such as are not
guarantees of general economic and business conditions, the ability to
successfully develop and market products, consumer and business consumption
habits, the ability to consummate successful acquisition and licensing
transactions, fluctuations in exchange rates, and other factors over which
Tauriga has little or no control. Many of these risks and uncertainties are discussed
in greater detail in the “Risk Factors” section of Tauriga’s Form 10-K and
other periodic filings made from time to time with the Securities and Exchange
Commission. Such forward-looking statements are made only as of the date of
this release, and Tauriga assumes no obligation to update forward-looking
statements to reflect subsequent events or circumstances. You should not place
undue reliance on these forward-looking statements.


Tauriga Sciences, Inc.

4 Nancy Court, Suite 4

Wappingers Falls, NY 12590

Chief Executive Officer

Mr. Seth M. Shaw


cell # (917) 796 9926

Company Instagram: @taurigum

Personal Instagram: 

Twitter: @SethMShaw

Corp. Website:

E-Commerce Website:

Source link

Show More

Related Articles

Back to top button